<Disease><Name>MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE)</Name><Synonym>MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME; TYMP</Synonym><OMIM><Number>603041</Number><URL>http://omim.org/entry/603041</URL></OMIM><Orphanet><Number>298</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=298</URL></Orphanet><Protein><Number>thymidine phosphorylase</Number><URL>http://www.uniprot.org/uniprot/P19971</URL></Protein><ExPASy><Number>2.4.2.4</Number><URL>http://enzyme.expasy.org/EC/2.4.2.4</URL></ExPASy><Gene>22q13.33</Gene><ICD>G71.3</ICD><Summary>rare;autosomal recessive;mutation of the TYMP gene</Summary><Symptoms><symtomp><id>2470</id><symptom>areflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3850</id><symptom>cachexia</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3628</id><symptom>gastrointestinal dysmotility</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3197</id><symptom>lactic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3351</id><symptom>leukoencephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2382</id><symptom>malabsorption</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>3369</id><symptom>neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2339</id><symptom>ophthalmoplegia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>2170</id><symptom>weight loss</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1695</id><name>Thymidine</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>3.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2074</id><name>Thymidine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.10</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2087</id><name>2-Deoxyuridine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2088</id><name>2-Deoxyuridine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>767</id><name>L-Lactic acid</name><specimen>jejunal biopsy</specimen><value>increased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>21</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>3.50</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>536</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>197.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>537</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>326.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>538</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>117.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>539</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>64.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1411</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>152.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>330</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>3.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>339</id><name>L-Lactic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.50</min><max>1.80</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>469</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>208</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>211</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>214</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>1.00</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>206</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>2.00</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>209</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.50</min><max>1.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>212</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.60</min><max>0.90</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>202</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>210</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>213</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.40</min><max>1.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1137</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.40</min><max>0.90</max><unit>mmol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>1136</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.60</max><unit>mmol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>203</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>204</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>1.00</min><max>1.50</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>207</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>2.00</min><max>3.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1813</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>45.00</min><max>410.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>2041</id><name>Thymidine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite></Metabolites><Literatures><literature><id>7930</id><title>Successful liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)</title><author>Kripps K,</author><journal>Mol Genet Metab</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7931</id><title>Quantification of Plasma and Urine Thymidine and 2-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients </title><author>Kipper K,</author><journal>J Clin Med</journal><year>2020</year><book /><volume>9</volume><number>3</number><pages>E788</pages><co_aut>et al.</co_aut></literature><literature><id>8129</id><title>Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNG</title><author>Hirano M,</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7932</id><title>Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands</title><author>Falcao de Campos C,</author><journal>Case Rep Neurol Med</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5285</id><title>A novel thymidine phosphorylase mutation in a Chinese MNGIE patient</title><author>Wang HF,</author><journal>Acta Neurol Belg</journal><year>2017</year><book /><volume>117</volume><number>1</number><pages>259-267</pages><co_aut>et al.</co_aut></literature><literature><id>5286</id><title>Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options</title><author>Yadak R,</author><journal>Front Cell Neurosci</journal><year>2017</year><book /><volume>11</volume><number>0</number><pages>31</pages><co_aut>et al.</co_aut></literature><literature><id>5287</id><title>Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa</title><author>Demaria F,</author><journal>J Adolesc Health</journal><year>2016</year><book /><volume>59</volume><number>6</number><pages>729-731</pages><co_aut>et al.</co_aut></literature><literature><id>5288</id><title>Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy</title><author>De Giorgio R,</author><journal>Ann Neurol</journal><year>2016</year><book /><volume>80</volume><number>3</number><pages>448-455</pages><co_aut>et al.</co_aut></literature><literature><id>5289</id><title>Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal </title><author>Torres-Torronteras J,</author><journal>Hum Gene Ther</journal><year>2016</year><book /><volume>27</volume><number>9</number><pages>656-667</pages><co_aut>et al.</co_aut></literature><literature><id>3532</id><title>Nutrition Therapy for Mitochondrial Neurogastrointestinal Encephalopathy with Homozygous Mutation of the TYMP Gene</title><author>Wang J,</author><journal>Clin Nutr Res</journal><year>2015</year><book /><volume>4</volume><number>2</number><pages>132-136</pages><co_aut>et al.</co_aut></literature><literature><id>3318</id><title>Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion</title><author>Sun R,</author><journal>Biochemistry</journal><year>2014</year><book /><volume>53</volume><number>39</number><pages>6142-6150</pages><co_aut>Wang L</co_aut></literature><literature><id>5295</id><title>Mitochondrial depletion syndromes in children and adults</title><author>Finsterer J,</author><journal>Can J Neurol Sci</journal><year>2013</year><book /><volume>40</volume><number>5</number><pages>635-644</pages><co_aut>Ahting U</co_aut></literature><literature><id>3319</id><title>Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications</title><author>Priego EM,</author><journal>Curr Pharm Des</journal><year>2012</year><book /><volume>18</volume><number>20</number><pages>2981-2994</pages><co_aut>et al.</co_aut></literature><literature><id>5283</id><title>Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MN</title><author>Taanman JW,</author><journal>Neuromuscul Disord</journal><year>2009</year><book /><volume>19</volume><number>2</number><pages>151-154</pages><co_aut>et al.</co_aut></literature><literature><id>3320</id><title>Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future</title><author>Perez-Perez MJ,</author><journal>Med Res Rev</journal><year>2008</year><book /><volume>28</volume><number>5</number><pages>797-820</pages><co_aut>et al.</co_aut></literature><literature><id>5290</id><title>Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion</title><author>Giordano C,</author><journal>Am J Pathol</journal><year>2008</year><book /><volume>173</volume><number>4</number><pages>1120-1128</pages><co_aut>et al.</co_aut></literature><literature><id>5284</id><title>Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations</title><author>Nishino I,</author><journal>Ann Neurol</journal><year>2000</year><book /><volume>47</volume><number>6</number><pages>792-800</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>